Effects of sulfasalazine on 6-mercaptopurine metabolism and clinical efficacy in patients with Crohn's disease: preliminary results of a placebo-controlled randomized clinical trial.

MLA

Achkar, Jean-Paul, et al. “Effects of Sulfasalazine on 6-Mercaptopurine Metabolism and Clinical Efficacy in Patients with Crohn’s Disease: Preliminary Results of a Placebo-Controlled Randomized Clinical Trial.” American Journal of Gastroenterology (Springer Nature), vol. 98, Sept. 2003, pp. S258–59. EBSCOhost, https://doi.org/10.1111/j.1572-0241.2003.08517.x.

APA

Achkar, J.-P., Brzezinski, A., Seidner, D., Vogel, D., Shen, B., & Lashner, B. (2003). Effects of sulfasalazine on 6-mercaptopurine metabolism and clinical efficacy in patients with Crohn’s disease: preliminary results of a placebo-controlled randomized clinical trial. American Journal of Gastroenterology (Springer Nature), 98, S258–S259. https://doi.org/10.1111/j.1572-0241.2003.08517.x

Chicago

Achkar, Jean-Paul, Aaron Brzezinski, Douglas Seidner, Deborah Vogel, Bo Shen, and Bret Lashner. 2003. “Effects of Sulfasalazine on 6-Mercaptopurine Metabolism and Clinical Efficacy in Patients with Crohn’s Disease: Preliminary Results of a Placebo-Controlled Randomized Clinical Trial.” American Journal of Gastroenterology (Springer Nature) 98 (September): S258–59. doi:10.1111/j.1572-0241.2003.08517.x.